WENZHOU, China, June 14, 2017 / PRNewswire/ -- Hebron Technology Co., Ltd. ("Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced that it has attended and sponsored the inaugural traditional Chinese medicine ("TCM") Industry Development Summit (the "Summit") which took place June 11, 2017 in Foshan City, Guangdong Province, China. The Summit, organized by the China Association of Traditional Chinese Medicine (the "CATCM") with Hebron among the co-sponsors, drew more than 100 attendees from government agencies, leading research institutes and more than 78 enterprises. Mr. Anyuan Sun, Chairman and Chief Executive Officer of Hebron, delivered a speech at the Summit, highlighting the recent developments at the Company following its successful IPO in December 2016, including new product development, project updates and new corporate initiatives.
"We are proud to join the CATCM as one of organizers and sponsors of the Summit, which brought together TCM industry leaders and academics from both China and Japan and provided a great venue for showcasing Hebron as not only a developer, manufacturer and installer of valves and pipe fittings but also a holistic engineering solution provider for pharmaceutical and TCM companies," said Mr. Sun.
About Hebron Technology Co., Ltd.
Established in January 2005 and headquartered in Wenzhou City, Zhejiang Province, China, Hebron Technology Co., Ltd. engages in research, development, and manufacture of highly specialized valves and pipe fitting products for use in the pharmaceutical, biological, food and beverage, and other clean industries. Hebron also offers its customers comprehensive pipeline design, installation, construction, and ongoing maintenance services as holistic solution services.
Forward-Looking Statements
This press release contains information about Hebron's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. Hebron encourages you to review other factors that may affect its future results in Hebron's registration statement and in its other filings with the Securities and Exchange Commission.
For more information, please contact:
At the Company
Yingping Chen, Secretary
Phone: +86-180-6776-3129
Investor Relations
Tony Tian, CFA
Weitian Group LLC
Email: tony.tian@weitian-ir.com
Phone: +1-732-910-9692
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hebron-technology-co-ltd-sponsors-tcm-industry-summit-300473234.html
